EUVIMEDEUVIMED entdecken
Crossref

A Sodium Alginate‐Based Multifunctional Nanoplatform for Synergistic Chemo‐Immunotherapy of Hepatocellular Carcinoma

Cong Huang, Ting Xie, Yufeng Liu, Shuang Yan, Feijun OuYang, Haitao Zhang, Longtianyang Lei, Dongxiu He, Hua Wei iD, Cui-Yun Yu

Advanced Materials · 2023

DOI: 10.1002/adma.202301352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Cong Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, Universi…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nanoparticles. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Hunan Science and Technology Innovation Leading Talent Project, Key R and D Program of Hunan Province, Postgraduate Scientific Research Innovation Project of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient hepatocellular carcinoma (HCC) treatment remains a significant challenge due to the inherent limitations of traditional strategies. The exploration of polysaccharides’ natural immunity for HCC immunotherapy is rarely explored. For this purpose, facile construction of a multifunctional nanoplatform, biotinylated aldehyde alginate‐doxorubicin nano micelle (BEACNDOXM) is reported in this study for synergistic chemo‐immunotherapy by using constant β ‐ D ‐mannuronic acid (M) units and modulated α ‐ L ‐guluronic acid (G) units in the alginate (ALG) structure. The M units show natural immunity and specific binding ability with mannose receptors (MRs) via strong receptor‐ligand interactions, and the G units serve as highly reactive conjugation sites for biotin (Bio) and DOX. Therefore, this formulation not only integrates the natural immunity of ALG and the immunogenic cell death (ICD) triggering function of DOX, but also shows dual targeting properties to HCC cells via MRs and Bio receptors (BRs)‐mediated endocytosis. Notably, BEACNDOXM mediates a tumor inhibitory efficiency 12.10% and 4.70% higher than free DOX and single targeting aldehyde alginate‐doxorubicin nano micelle controls, respectively, at an equivalent DOX dose of 3 mg kg −1 in Hepa1‐6 tumor‐bearing mice. This study reports the first example of integrating the natural immunity of ALG and the ICD effect of anticancer drugs for enhanced chemo‐immunotherapy of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNanoparticlesAnimalsMiceAlginatesDoxorubicinImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

G unitsM unitschemo-immunotherapyhepatocellular carcinomasodium alginate

Substanzen

AlginatesDoxorubicin

Autor:innen und Institutionen

  • Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, 421001, P. R. China.

ORCID-Profile: Hua Wei

Förderung

  • Hunan Science and Technology Innovation Leading Talent Project
  • Key R and D Program of Hunan Province
  • Postgraduate Scientific Research Innovation Project of Hunan Province

Zitieren

APA

Huang, C., Xie, T., Liu, Y., Yan, S., OuYang, F., Zhang, H., Lei, L., He, D., Wei, H., & Yu, C. Y. (2023). A Sodium Alginate‐Based Multifunctional Nanoplatform for Synergistic Chemo‐Immunotherapy of Hepatocellular Carcinoma. Advanced Materials. https://doi.org/10.1002/adma.202301352

Vancouver

Huang C, Xie T, Liu Y, Yan S, OuYang F, Zhang H, et al. A Sodium Alginate‐Based Multifunctional Nanoplatform for Synergistic Chemo‐Immunotherapy of Hepatocellular Carcinoma. Advanced Materials. 2023. doi:10.1002/adma.202301352

BibTeX
@article{Huang2023,
  author = {Huang, Cong and Xie, Ting and Liu, Yufeng and Yan, Shuang and OuYang, Feijun and Zhang, Haitao and Lei, Longtianyang and He, Dongxiu and Wei, Hua and Yu, Cui-Yun},
  title = {A Sodium Alginate‐Based Multifunctional Nanoplatform for Synergistic Chemo‐Immunotherapy of Hepatocellular Carcinoma},
  journal = {Advanced Materials},
  year = {2023},
  doi = {10.1002/adma.202301352}
}
Kostenlos starten →